P20-CA233307/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2017	1
2018	2
2019	5
2020	4
2021	8
2022	7
2023	14
2024	4

1

Palliative Care Use Trends, Racial/Ethnic Disparities, and Overall Survival Differences Among Patients With Metastatic Breast Cancer.

Freeman JQ, Omoleye OJ, Zhao F, Huo D. Freeman JQ, et al. J Palliat Med. 2024 Feb 1. doi: 10.1089/jpm.2023.0547. Online ahead of print. J Palliat Med. 2024. PMID: 38301120

2

Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia.

Ochs-Balcom HM, Preus L, Du Z, Elston RC, Teerlink CC, Jia G, Guo X, Cai Q, Long J, Ping J, Li B, Stram DO, Shu XO, Sanderson M, Gao G, Ahearn T, Lunetta KL, Zirpoli G, Troester MA, Ruiz-Narváez EA, Haddad SA, Figueroa J, John EM, Bernstein L, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Mancuso N, Press MF, Deming SL, Rodriguez-Gil JL, Yao S, Ogundiran TO, Ojengbede O, Bolla MK, Dennis J, Dunning AM, Easton DF, Michailidou K, Pharoah PDP, Sandler DP, Taylor JA, Wang Q, O'Brien KM, Weinberg CR, Kitahara CM, Blot W, Nathanson KL, Hennis A, Nemesure B, Ambs S, Sucheston-Campbell LE, Bensen JT, Chanock SJ, Olshan AF, Ambrosone CB, Olopade OI, The Ghana Breast Health Study Team, Conti DV, Palmer J, García-Closas M, Huo D, Zheng W, Haiman C. Ochs-Balcom HM, et al. Hum Mol Genet. 2024 Apr 8;33(8):687-697. doi: 10.1093/hmg/ddae002. Hum Mol Genet. 2024. PMID: 38263910

3

Validation of the RSClin risk calculator in the National Cancer Data Base.

Vannier AGL, Dhungana A, Zhao F, Chen N, Shubeck S, Hahn OM, Nanda R, Jaskowiak NT, Fleming GF, Olopade OI, Pearson AT, Huo D, Howard FM. Vannier AGL, et al. Cancer. 2024 Apr 15;130(8):1210-1220. doi: 10.1002/cncr.35163. Epub 2023 Dec 26. Cancer. 2024. PMID: 38146744

4

External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population.

Omoleye OJ, Woodard AE, Howard FM, Zhao F, Yoshimatsu TF, Zheng Y, Pearson AT, Levental M, Aribisala BS, Kulkarni K, Karczmar GS, Olopade OI, Abe H, Huo D. Omoleye OJ, et al. Radiol Artif Intell. 2023 Jul 26;5(6):e220299. doi: 10.1148/ryai.220299. eCollection 2023 Nov. Radiol Artif Intell. 2023. PMID: 38074785 Free PMC article.

5

Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.

Freeman JQ, Khwaja A, Zhao F, Nanda R, Olopade OI, Huo D. Freeman JQ, et al. Telemed J E Health. 2024 Mar;30(3):651-663. doi: 10.1089/tmj.2023.0225. Epub 2023 Sep 7. Telemed J E Health. 2024. PMID: 37676974

6

Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.

Ren Z, Pineda FD, Howard FM, Fan X, Nanda R, Abe H, Kulkarni K, Karczmar GS. Ren Z, et al. Magn Reson Imaging. 2023 Aug 21;104:9-15. doi: 10.1016/j.mri.2023.08.003. Online ahead of print. Magn Reson Imaging. 2023. PMID: 37611646

7

Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic Cohort.

Zhao F, Freeman JQ, Jaskowiak N, Fleming GF, Nanda R, Lauderdale DS, Olopade OI, Huo D. Zhao F, et al. Res Sq [Preprint]. 2023 Aug 10:rs.3.rs-3231825. doi: 10.21203/rs.3.rs-3231825/v1. Res Sq. 2023. PMID: 37609132 Free PMC article. Preprint.

8

Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer.

Freeman JQ, Sheade J, Zhao F, Olopade OI, Nanda R, Huo D. Freeman JQ, et al. Integr Cancer Ther. 2023 Jan-Dec;22:15347354231185122. doi: 10.1177/15347354231185122. Integr Cancer Ther. 2023. PMID: 37462224 Free PMC article.

9

A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes.

Gao G, Fiorica PN, McClellan J, Barbeira AN, Li JL, Olopade OI, Im HK, Huo D. Gao G, et al. Am J Hum Genet. 2023 Jun 1;110(6):950-962. doi: 10.1016/j.ajhg.2023.04.005. Epub 2023 May 9. Am J Hum Genet. 2023. PMID: 37164006 Free PMC article.

10

Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence.

Howard FM, Dolezal J, Kochanny S, Khramtsova G, Vickery J, Srisuwananukorn A, Woodard A, Chen N, Nanda R, Perou CM, Olopade OI, Huo D, Pearson AT. Howard FM, et al. NPJ Breast Cancer. 2023 Apr 14;9(1):25. doi: 10.1038/s41523-023-00530-5. NPJ Breast Cancer. 2023. PMID: 37059742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year